N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma

Breast Cancer Research

Volumn 16, Issue 2, 2014, Pages

  Ma, Ji ^a,b,c   Liu, Wenchao ^b   Guo, Hang ^a,b   Li, Shaoqing ^a   Cao, Wei ^d   Du, Xilin ^d   Lei, Shixiong ^d   Hou, Wugang ^b   Xiong, Lize ^b   Yao, Libo ^a   Li, Nanlin ^b   Li, Yan ^a,b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c LANZHOU GENERAL HOSPITAL   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; PROTEIN C MYB; NDRG2 PROTEIN, HUMAN; PROTEIN BINDING; SLC2A1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE FREE SURVIVAL; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; MOUSE; N MYC DOWNSTREAM REGULATED GENE 2; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; UBIQUITINATION; XENOGRAFT;

ANIMALS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 84899068536     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3628     Document Type: Article

References (40)

1. Yao L, Zhang J, Liu X. NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin (Shanghai) 2008, 40:625-635. 10.1111/j.1745-7270.2008.00434.x, 18604454.
2. Deng Y, Yao L, Chau L, Ng SS, Peng Y, Liu X, Au WS, Wang J, Li F, Ji S, Han H, Nie X, Li Q, Kung HF, Leung SY, Lin MC. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 2003, 106:342-347. 10.1002/ijc.11228, 12845671.
3. Liu J, Yang L, Zhang J, Zhang J, Chen Y, Li K, Li Y, Li Y, Yao L, Guo G. Knock-down of NDRG2 sensitizes cervical cancer HeLa cells to cisplatin through suppressing Bcl-2 expression. BMC Cancer 2012, 12:370. 10.1186/1471-2407-12-370, 3493279, 22920753.
4. Liu N, Wang L, Li X, Yang Q, Liu X, Zhang J, Zhang J, Wu Y, Ji S, Zhang Y, Yan A, Han H, Yao L. N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis. Nucleic Acids Res 2008, 36:5335-5349. 10.1093/nar/gkn504, 2532733, 18689861.
5. Ma J, Liu W, Yan X, Wang Q, Zhao Q, Xue Y, Ren H, Wu L, Cheng Y, Li S, Miao L, Yao L, Zhang J. Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells. PloS One 2012, 7:e32368. 10.1371/journal.pone.0032368, 3290656, 22393400.
6. Oh S, Kim D, Kim DH, Chang HH, Sohn KC, Kim KH, Jung SH, Lee BK, Kim JH, Kim KD. NDRG2 correlated with favorable recurrence-free survival inhibits metastasis of mouse breast cancer cells via attenuation of active TGF-β production. Carcinogenesis 2012, 33:1882-1888. 10.1093/carcin/bgs211, 22696597.
7. Nichols NR. Ndrg2, a novel gene regulated by adrenal steroids and antidepressants, is highly expressed in astrocytes. Ann N Y Acad Sci 2003, 1007:349-356. 10.1196/annals.1286.034, 14993068.
8. Foletta VC, Prior MJ, Stupka N, Carey K, Segal DH, Jones S, Swinton C, Martin S, Cameron-Smith D, Walder KR. NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol 2009, 587:1619-1634. 10.1113/jphysiol.2008.167882, 2678230, 19204049.
9. Takahashi K, Saitoh A, Yamada M, Iwai T, Inagaki M, Yamada M. Dexamethasone indirectly induces Ndrg2 expression in rat astrocytes. J Neurosci Res 2012, 90:160-166. 10.1002/jnr.22727, 21928335.
10. Burchfield JG, Lennard AJ, Narasimhan S, Hughes WE, Wasinger VC, Corthals GL, Okuda T, Kondoh H, Biden TJ, Schmitz-Peiffer C. Akt mediates insulin-stimulated phosphorylation of Ndrg2: evidence for cross-talk with protein kinase Cθ. J Biol Chem 2004, 279:18623-18632.
11. Shen L, Liu X, Hou W, Yang G, Wu Y, Zhang R, Li X, Che H, Lu Z, Zhang Y, Liu X, Yao L. NDRG2 is highly expressed in pancreatic β cells and involved in protection against lipotoxicity. Cell Mol Life Sci 2010, 67:1371-1381. 10.1007/s00018-010-0258-1, 20127388.
12. Sun Z, Tong G, Ma N, Li J, Li X, Li S, Zhou J, Xiong L, Cao F, Yao L, Wang H, Shen L. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Basic Res Cardiol 2013, 108:341.
13. Boulkroun S, Le Moellic C, Blot-Chabaud M, Farman N, Courtois-Coutry N. Expression of androgen receptor and androgen regulation of NDRG2 in the rat renal collecting duct. Pflugers Arch 2005, 451:388-394. 10.1007/s00424-005-1410-x, 16142456.
14. Li Y, Yang J, Li S, Zhang J, Zheng J, Hou W, Zhao H, Guo Y, Liu X, Dou K, Situ Z, Yao L. N-myc downstream-regulated gene 2, a novel estrogen-targeted gene, is involved in the regulation of Na+/K+-ATPase. J Biol Chem 2011, 286:32289-32299. 3173200, 21771789.
15. Boulkroun S, Fay M, Zennaro MC, Escoubet B, Jaisser F, Blot-Chabaud M, Farman N, Courtois-Coutry N. Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem 2002, 277:31506-31515.
16. Murray JT, Campbell DG, Morrice N, Auld GC, Shpiro N, Marquez R, Peggie M, Bain J, Bloomberg GB, Grahammer F, Lang F, Wulff P, Kuhl D, Cohen P. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem J 2004, 384:477-488. 10.1042/BJ20041057, 1134133, 15461589.
17. Wielpütz MO, Lee IH, Dinudom A, Boulkroun S, Farman N, Cook DI, Korbmacher C, Rauh R. (NDRG2) stimulates amiloride-sensitive Na+ currents in Xenopus laevis oocytes and Fisher rat thyroid cells. J Biol Chem 2007, 282:28264-28273.
18. Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res 2002, 35:9-26.
19. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927, 8:519-530. 10.1085/jgp.8.6.519, 2140820, 19872213.
20. Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab 2011, 14:443-451. 10.1016/j.cmet.2011.07.014, 3196640, 21982705.
21. Augustin R. The protein family of glucose transport facilitators: it's not only about glucose after all. IUBMB Life 2010, 62:315-333.
22. Adekola K, Rosen ST, Shanmugam M. Glucose transporters in cancer metabolism. Curr Opin Oncol 2012, 24:650-654. 10.1097/CCO.0b013e328356da72, 22913968.
23. Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG, Soares FA. GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo) 2011, 66:965-972. 10.1590/S1807-59322011000600008, 3129958, 21808860.
24. Chan DA, Sutphin PD, Nguyen P, Turcotte S, Lai EW, Banh A, Reynolds GE, Chi JT, Wu J, Solow-Cordero DE, Bonnet M, Flanagan JU, Bouley DM, Graves EE, Denny WA, Hay MP, Giaccia AJ. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med 2011, 3:94ra70. 3683134, 21813754.
25. Amann T, Hellerbrand C. GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 2009, 13:1411-1427. 10.1517/14728220903307509, 19874261.
26. Basturk O, Singh R, Kaygusuz E, Balci S, Dursun N, Culhaci N, Adsay NV. GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis. Pancreas 2011, 40:187-192. 10.1097/MPA.0b013e318201c935, 3164314, 21206329.
27. Shen L, Sun X, Fu Z, Yang G, Li J, Yao L. The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy. Clin Cancer Res 2012, 18:1561-1567. 10.1158/1078-0432.CCR-11-3040, 22307140.
28. Zheng J, Liu Q, Li Y, Yang J, Ma J, Yu F, Shi H, Ren Q, Zhang R, Zhang J, Xue Y, Tao Y, Jiang N, Guo H, Yao L, Liu W. NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells. Asian Pac J Cancer Prev 1817-1821, 2010:11.
29. Shon SK, Kim A, Kim JY, Kim KI, Yang Y, Lim JS. Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun 2009, 385:198-203. 10.1016/j.bbrc.2009.05.038, 19450561.
30. Park Y, Shon SK, Kim A, Kim KI, Yang Y, Cho DH, Lee MS, Lim JS. SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells. Biochem Biophys Res Commun 2007, 363:361-367. 10.1016/j.bbrc.2007.08.195, 17888401.
31. Liu N, Wang L, Liu X, Yang Q, Zhang J, Zhang W, Wu Y, Shen L, Zhang Y, Yang A, Han H, Zhang J, Yao L. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem Biophys Res Commun 2007, 358:164-169. 10.1016/j.bbrc.2007.04.089, 17470364.
32. Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C. Expression profile of the N-myc downstream regulated gene 2 (NDRG2) in human cancers with focus on breast cancer. BMC Cancer 2011, 11:14. 10.1186/1471-2407-11-14, 3024299, 21226903.
33. Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res 2004, 64:2627-2633. 10.1158/0008-5472.CAN-03-0846, 15059920.
34. Kawauchi K, Araki K, Tobiume K, Tanaka N. p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation. Nat Cell Biol 2008, 10:611-618. 10.1038/ncb1724, 18391940.
35. Zhang J, Li F, Liu X, Shen L, Liu J, Su J, Zhang W, Deng Y, Wang L, Liu N, Han W, Zhang J, Ji S, Yang A, Han H, Yao L. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J Biol Chem 2006, 281:39159-39168.
36. Wang L, Liu N, Yao L, Li F, Zhang J, Deng Y, Liu J, Ji S, Yang A, Han H, Zhang Y, Zhang J, Han W, Liu X. NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells. Cell Physiol Biochem 2008, 21:239-250. 10.1159/000113765, 18209490.
37. Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, Xu Y, Wonsey D, Lee LA, Dang CV. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 2000, 275:21797-21800.
38. Chung FY, Huang MY, Yeh CS, Chang HJ, Cheng TL, Yen LC, Wang JY, Lin SR. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients. BMC Cancer 2009, 9:241. 10.1186/1471-2407-9-241, 3087329, 19619276.
39. Zhang J, Liu J, Li X, Li F, Wang L, Zhang J, Liu X, Shen L, Liu N, Deng Y, Yang A, Han H, Zhao M, Yao L. The physical and functional interaction of NDRG2 with MSP58 in cells. Biochem Biophys Res Commun 2007, 352:6-11. 10.1016/j.bbrc.2006.10.141, 17109818.
40. Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y, He F. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 2002, 229:35-44. 10.1023/A:1017934810825, 11936845.